A clinical study to evaluate the efficiency of two drugs to stop bleeding after wisdom tooth removal
Phase 2
- Conditions
- Health Condition 1: K011- Impacted teeth
- Registration Number
- CTRI/2022/08/045102
- Lead Sponsor
- Self Dr Parvaket Patel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients indicated for surgical extraction of impacted mandibular third molars
2.Patients willing to participate in the study
3.Patients undergoing oral anticoagulative therapy requiring surgical extraction of mandibular third molars
4.Patients without any history of chronic illness
Exclusion Criteria
1.Patients who are allergic to shellfish
2.Patients who are allergic to gelatin/gelatin-based products
3.Patients presenting in a hypercoagulable state
4.Patients with renal dysfunction, liver disorders, asthma, pregnancy.
5.Patients allergic to Chitosan/ Chitin and its byproducts.
6.Patients with an intellectual deficit
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method